Increased expression levels of IL-17 at day 3 were also found in the other Hp-primed gastric cancer GSCs T9 (Fig. 1f), which was significantly blocked by the addition of IL-23-neutralizing Abs (Fig. 1g). This evidence concerns the gene IL17A and gastric cancer.